NEPHROS INC
NEPHNASDAQ🏆 #3568 by market capUS Equity
$4.27▲ $0.00 (+0.00%)
Market closed · at close1h—
24h▲ 0.0%
7d▲ 22.9%
14d▲ 17.3%
30d▲ 24.9%
1y▲ 5.0%
🏦Market Cap
$46M
Small Cap
📈Revenue Growth (YoY)
+23.3%
Healthy
📊Gross Margin
60.0%
Healthy
💵FCF Margin
8.6%
Moderate
⚖️P/S Ratio
2.5x
Cheap
Otter Score
61
Fair
Trading Snapshot
- Day Range
- $4.23 – $4.29
- 52-Week Range
- $2.66 – $6.42
- Volume
- $4.92B
- Avg Volume
- $5.71B
- Shares Outstanding
- 10.9M
- Next Earnings
- Oct 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $5M
- P/E Ratio
- 60.9
- P/S Ratio
- 2.5x
- EPS (TTM)
- $0.07
- Dividend Yield
- —
Why Investors Own NEPH
- ✓High-growth profile — revenue up -6.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 35% gross margin and 19% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$19M▼ −10.0% YoY
Gross Margin (TTM)
34.9%▲ +1.8% YoY
Operating Income (TTM)
$4M▼ −10.0% YoY
Free Cash Flow (TTM)
$4M▼ −10.0% YoY
About NEPHROS INC
A company profile for NEPHROS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
61/100
Analyst Price Target
ⓘAverage Target
$5.18
▲ +21.4% Upside
High Target$5.97
Low Target$4.47
Based on 19 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
NEPHROS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift NEPH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
NEPHROS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.